Lombard Odier Asset Management Europe Ltd purchased a new position in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 172,971 shares of the company’s stock, valued at approximately $13,668,000.
A number of other hedge funds have also recently added to or reduced their stakes in CL. Kemnay Advisory Services Inc. bought a new stake in Colgate-Palmolive during the 4th quarter valued at $25,000. CBIZ Investment Advisory Services LLC lifted its stake in shares of Colgate-Palmolive by 86.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock valued at $26,000 after buying an additional 150 shares in the last quarter. Triumph Capital Management grew its holdings in shares of Colgate-Palmolive by 62.9% during the fourth quarter. Triumph Capital Management now owns 329 shares of the company’s stock valued at $26,000 after buying an additional 127 shares during the last quarter. Jessup Wealth Management Inc acquired a new position in shares of Colgate-Palmolive during the fourth quarter valued at about $26,000. Finally, Maseco LLP bought a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $27,000. Institutional investors and hedge funds own 80.41% of the company’s stock.
Colgate-Palmolive Trading Down 0.0%
NYSE:CL opened at $90.56 on Wednesday. The firm’s 50 day moving average is $87.07 and its 200 day moving average is $86.45. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The stock has a market capitalization of $72.47 billion, a PE ratio of 35.24, a price-to-earnings-growth ratio of 4.78 and a beta of 0.33. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33.
Colgate-Palmolive Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be given a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio is 82.49%.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on CL shares. Morgan Stanley reiterated an “overweight” rating on shares of Colgate-Palmolive in a research note on Monday, May 4th. The Goldman Sachs Group reissued a “buy” rating on shares of Colgate-Palmolive in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $99.00 price objective on shares of Colgate-Palmolive in a research report on Monday, May 4th. Barclays lifted their target price on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 5th. Finally, JPMorgan Chase & Co. boosted their target price on Colgate-Palmolive from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, May 4th. Twelve investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $95.88.
View Our Latest Stock Analysis on CL
Colgate-Palmolive Company Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Read More
- Five stocks we like better than Colgate-Palmolive
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
